ENTA Stock Analysis: Buy, Sell, or Hold?
ENTA - Enanta Pharmaceuticals, Inc
$13.19
0.29 (2.25%)
▲
5d:
+2.09%
30d:
-16.36%
90d:
+21.45%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 09, 2026
5d
Get Alerted When ENTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ENTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ENTA is currently trading at $13.19, which is considered fair relative to its 30-day fair value range of $12.44 to $14.89.
Technical Outlook: Technically, ENTA is in a strong uptrend. Immediate support is located at $12.09, while resistance sits at $13.98.
Market Sentiment: ENTA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.12 (+45.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENTA is in a strong uptrend. Immediate support is located at $12.09, while resistance sits at $13.98.
Market Sentiment: ENTA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.12 (+45.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$12.44 -
$14.89
Company Quality Score
55/100
(HOLD)
Options IV Signal
30th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
54.2%
Protect Your Profits
Holding ENTA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 30th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.0% below Wall St target ($19.12)
Fair Price Analysis
30-Day Fair Range
$12.44 -
$14.89
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$2.82
(21.4%)
Support & Resistance Levels
Support Level
$12.09
Resistance Level
$13.99
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.82
Wall Street Target
$19.13
(+45.0%)
Revenue Growth (YoY)
3.5%
Earnings Growth (YoY)
-66.2%
Profit Margin
-125.4%
Last updated: February 03, 2026 6:50 AM ET
Data refreshes hourly during market hours. Next update: 7:50 AM
Data refreshes hourly during market hours. Next update: 7:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 63 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 48 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 54 HOLD |
Advanced ENTA Option Strategies
Professional options setups generated by AI based on today's ENTA price and gamma walls.
